Lexeo Therapeutics (LXEO) Profit After Tax (2022 - 2026)

Lexeo Therapeutics (LXEO) reported Profit After Tax of -$20.2 million for Q1 2026, up 38.16% on a YoY basis from -$14.6 million in Q1 2025, and up 3.83% sequentially from -$21.0 million in Q4 2025.

Lexeo Therapeutics (LXEO) Profit After Tax (2022 - 2026) Analysis & Trends

Lexeo Therapeutics (LXEO) has 5 years of Profit After Tax data on file, last reported at -$20.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Profit After Tax rose 38.16% year-over-year to -$20.2 million; the trailing twelve-month figure through Mar 2026 stood at -$87.6 million (up 19.88% YoY), and the FY2025 full-year result was -$100.0 million, down 1.7% from the prior year.
  • Profit After Tax advanced to -$20.2 million in Q1 2026, from -$21.0 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$13.4 million in Q2 2023 to a low of -$32.7 million in Q1 2025.
  • A 5-year average of -$21.1 million and a median of -$20.3 million in 2025 frame the typical range for Profit After Tax.
  • Across the five-year window, Profit After Tax tumbled 82.65% in 2024 and jumped 38.16% in 2026, its largest moves.
  • Tracing LXEO's Profit After Tax over 5 years: stood at -$14.6 million in 2022, then advanced by 2.79% to -$14.2 million in 2023, then tumbled by 82.65% to -$25.9 million in 2024, then advanced by 18.99% to -$21.0 million in 2025, then grew by 3.83% to -$20.2 million in 2026.
  • Business Quant data shows LXEO's Profit After Tax at -$20.2 million in Q1 2026, -$21.0 million in Q4 2025, and -$20.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -36.84 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 227.36 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -65.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 362.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 Lexeo Therapeutics 382.38 Mn 382.38 Mn - -20.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -20.20 Mn
Dec 31, 2025 -21.00 Mn
Sep 30, 2025 -20.28 Mn
Jun 30, 2025 -26.10 Mn
Mar 31, 2025 -32.66 Mn
Dec 31, 2024 -25.92 Mn
Sep 30, 2024 -29.49 Mn
Jun 30, 2024 -21.24 Mn
Mar 31, 2024 -21.68 Mn
Dec 31, 2023 -14.19 Mn
Sep 30, 2023 -20.11 Mn
Jun 30, 2023 -13.44 Mn
Mar 31, 2023 -18.66 Mn
Dec 31, 2022 -14.60 Mn
Sep 30, 2022 -17.06 Mn